In accordance with the ACCME Standards for Integrity and Independence, the Association of Diabetes Care & Education Specialists (ADCES) requires anyone in a position to affect or control continuing education content (e.g., authors, presenters, and program planners) to disclose all financial relationships with ineligible companies. It is the responsibility of ADCES to mitigate and disclose all relevant conflicts of interest. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:Speakers
Sacha Uelmen, RDN, CDCES – No conflicts of interestPlanners
Amy Carter, RDN, CDCES – No conflicts of interest
Jodi Lavin-Tompkins, MSN, RN, CDCES, BC-ADM – Stock: Gilead Sciences, Regeneron Pharma
Sacha Uelmen, RDN, CDCES – No conflicts of interest
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Disclosure and Mitigation of Relevant Conflicts of Interest
All identified relevant conflicts of interest have been mitigated.